Novartis takes a look at the unconventional

31 January 2014 - Deborah Wilkes

Archived

Different or unconventional structures are on the agenda as Novartis reviews all the strategic options for its global OTC business and two other smaller businesses.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: